Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Espeland MA, et al. Among authors: hunninghake d. Am J Epidemiol. 1995 Nov 15;142(10):1011-9. doi: 10.1093/oxfordjournals.aje.a117553. Am J Epidemiol. 1995. PMID: 7485045 Clinical Trial.
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy.
Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, Riley W, Craven T, Chaput L, Ireland CC, Applegate WB; Heart and Estrogen/Progestin Replacement Study Research Group. Byington RP, et al. Among authors: hunninghake d. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1692-7. doi: 10.1161/01.atv.0000033514.79653.04. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377751 Clinical Trial.
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators.
Miller M, Byington R, Hunninghake D, Pitt B, Furberg CD. Miller M, et al. Among authors: hunninghake d. Arch Intern Med. 2000 Feb 14;160(3):343-7. doi: 10.1001/archinte.160.3.343. Arch Intern Med. 2000. PMID: 10668836 Clinical Trial.
212 results